John Segreti to Campylobacter Infections
This is a "connection" page, showing publications John Segreti has written about Campylobacter Infections.
Connection Strength
0.034
-
In vitro activity of new quinoxaline compounds against Campylobacter species and Clostridium difficile. Diagn Microbiol Infect Dis. 1993 Aug-Sep; 17(2):177-9.
Score: 0.028
-
Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med. 1990 Mar; 150(3):541-6.
Score: 0.006